CDH1 and hepatocellular carcinoma: In contrast to individual monotherapies, the combination therapy significantly inhibited the EMT of HCC cells, as manifested by higher expression of E-cadherin and lower expression of Snail (P-values < 0.05) (Figure 2C, 2D).